Viking Therapeutics stock skidded Wednesday despite the "encouraging" speed with which the company enrolled patients in an obesity study.

Through his X handler, Kamath revealed that he has been following the developments around Ozempic and GLP-1 drugs with some ...

India has developed its first indigenous MRI scanner, which will be installed at AIIMS-Delhi by October 2025. The initiative ...

“While the weight loss results were impressive across the group, the cost and side effects remain important barriers for long ...

The Nifty 50 and Sensex ended a seven-day winning streak, posting their biggest intraday fall in nearly a month. The Nifty ...

Billions of dollars in annual revenue and the health of millions of patients are at stake in a drug industry battle over who ...

Mounjaro, a weekly injection, targets GIP and GLP-1 hormones to enhance insulin release and appetite regulation, aiding ...

Eli Lilly and Novo Nordisk are in a global battle for dominance in the weight loss space. BioSpace takes a look at the ...

Eli Lilly's CEO, David Ricks, reveals potential plans to manufacture the weight-loss drug Mounjaro in India as part of their global expansion.

JM Financial is bullish on Mounjaro's success in India, citing its price advantage, higher efficiency and the country's large ...

Investing in stocks remains one of the best ways to accumulate capital over long periods. Companies that can last -- and ...

Mounjaro, a weight loss drug launched by Eli Lilly in India, could be a game-changer and has been making waves lately. Here's ...